Szilvia Mosolits
About Szilvia Mosolits
Szilvia Mosolits is the Director and Publication Team Lead for Gastrointestinal Cancers at Bristol Myers Squibb, with extensive experience in immuno-oncology and a strong background in medical affairs and scientific publications across multiple countries.
Title and Current Role
Szilvia Mosolits is currently serving as the Director and Publication Team Lead for Gastrointestinal Cancers at Bristol Myers Squibb, headquartered in New Jersey, United States.
Previous Roles at Bristol Myers Squibb
Before her current role, Szilvia Mosolits held multiple positions at Bristol Myers Squibb. From 2015 to 2020, she served as Director, Publication Lead, focusing on Gastrointestinal cancers, Hepatitis C, and Fibrosis. Prior to this, she was the Associate Medical Director for Hepatitis C from 2013 to 2015, and the Disease Area Specialist for Hepatitis C and B from 2010 to 2013, based in Madrid, Spain.
Experience in the Pharmaceutical Industry
In addition to her extensive tenure at Bristol Myers Squibb, Szilvia Mosolits has worked with other major pharmaceutical companies. From 2007 to 2009, she was the European Medical Advisor for Benign Prostatic Hyperplasia at GlaxoSmithKline in Madrid, Spain. At Laboratorios Almirall S.A., she worked as a Clinical Research Physician and Clinical Trial Manager from 2005 to 2007 in Barcelona, Spain. Earlier in her career, she was a Scientist specializing in Immuno-oncology at GlaxoSmithKline in the United Kingdom.
Academic Background
Szilvia Mosolits holds a Ph.D. in Immuno-oncology from the Karolinska Institute in Stockholm, Sweden, where she studied from 1997 to 2003. She also earned her Doctor of Medicine (M.D.) degree from the University of Pécs, Faculty of Medicine in Pécs, Hungary, completing her studies from 1987 to 1993.
Global Experience and Multilingual Skills
Szilvia Mosolits has held roles in various countries, including Spain, Sweden, the United Kingdom, and the United States. Her international experience and multilingual capabilities have likely enhanced her effectiveness in global collaboration and cross-cultural communication within the pharmaceutical industry.